Abstract Introduction Artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCTIschemia), is a non-invasive tool to evaluate myocardial ischemia associated with coronary artery disease on a per vessel basis. Prior individual cohorts have demonstrated a strong diagnostic performance of AI-QCTIschemi. as compared to invasive fractional flow reserve (FFR). Purpose To evaluate the diagnostic performance of AI-QCTIschemia versus fractional flow reserve computed tomography (FFR-CT), using invasive FFR as the reference standard. Patient-level data from four cohort studies were pooled to enable assessment of clinically important subgroups: men, women, patients ≤60 or 60 years, and those with or without diabetes. Methods This analysis pooled patient and vessel level data from 592 patients and 1575 vessels from four cohorts undergoing CCTA with comparison of AI-QCTIschemia and FFR-CT. FFR-CT and invasive FFR 0.8 were considered positive for ischemia. Sensitivity, specificity, and AUC were compared between subgroups using Generalized Estimating Equations models and DeLong’s test. Uninterpretable test results were considered positive. Results Mean age was 62 years, and 32% were females. A total of 356 (60.1%) of vessels had 50% stenosis, with 230 (38.9%) involving the proximal LAD. At the vessel level, 494 (28.6%) were characterized as mild stenosis (25-49%), 270 (16%) moderate (50-69%), and 173 (10%) severe (70-99%). These results were then subclassified based on gender, age (60 or ≤60), and those with or without diabetes. Across all three key clinical cohorts, AI-QCTIschemia demonstrated higher diagnostic accuracy for detection of vessel level ischemia. Conclusion In this pooled analysis, we demonstrated that AI-QCTIschemia a model which emphasizes vessel characterization of coronary artery disease to predict myocardial ischemia showed higher diagnostic accuracy than a computational fluid dynamics-based prediction model to predict vessel level ischemia across clinically relevant subgroups: women, older adults, and diabetics.
Beckmann et al. (Sat,) studied this question.